Since 2020, various COVID-19 test kits manufactured by Wondfo Biotech have greatly assisted in the global fight against the pandemic. Wondfo has intently tracked variants of Coronavirus arising around the world and we attach significance to the impact of variants on testing.
Regarding variants of Coronavirus reported by WHO, Wondfo has conducted assessment and verification of effectiveness of our 2019-nCoV Real-Time RT-PCR Tests (CE) and 2019-nCoV Antigen Tests (NMPA/CE) in detecting major variants, including bioinformatic comparison and test verification with collected samples. According to verification, Wondfo’s COVID-19 tests can effectively detect variants of Coronavirus, including Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), Lambda (C.37), Zeta (P.2), Eta (B.1.525), Iota (B.1.526), Kappa (B.1.617.1), Fin-796H, N.9, B.1.616, Epsilon (B.1.429+B.1.427), Theta (P.3), and Mu (B.1.621).
Regarding the latest variant of Coronavirus, Wondfo’s test kits can effectively detect the Omicron variant (B.1.1.529) based on bioinformatic analysis, and lab tests are being conducted for further assessment.
Wondfo will keep tracking the latest information to ensure that COVID-19 test kits manufactured and sold by us can detect most variants and to avoid off-target results or false negative results.